The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt
OBJECTIVE: The inflammatory biomarker YKL-40 is elevated and associated with mortality in patients with stable coronary artery disease (CAD). The aim was to investigate the influence of statin treatment and lipid status on serum YKL-40 and Hs-CRP in patients with stable CAD. DESIGN: Serum YKL-40, HsCRP, total cholesterol, HDL-c, LDL-c and triglycerides levels were measured in 404 statin treated and in 404 matched non-statin treated patients with stable CAD. RESULTS: YKL-40 was significantly higher in non-statin treated 110 µg/l (median) compared with 65 µg/l in statin treated (p
Originalsprog | Engelsk |
---|---|
Tidsskrift | Inflammation Research |
Vol/bind | 60 |
Udgave nummer | 3 |
Sider (fra-til) | 281-7 |
Antal sider | 7 |
ISSN | 1023-3830 |
DOI | |
Status | Udgivet - 2011 |
ID: 32108354